Tag: CSL
Australia’s CSL outlines USD 1.5B plan to boost US plasma therapy manufacturing capacity
Australian biotech firm CSL has announced plans to invest approximately USD 1.5 billion in the United States over the next five years, with the company stating the move is aimed at strengthening domestic manufacturing capacity for plasma-derived therapies.
CSL boosts AU’s plasma manufacturing capability with new Fractionation Facility
Global biotech company CSL has opened a new $900 million Plasma Fractionation Facility in Victoria, bolstering the future of plasma manufacturing in Australia.
CSL dispatches first Australian made doses of AstraZeneca COVID-19 Vaccine
CSL has announced the first of the Australian made AstraZeneca COVID-19 Vaccine have been dispatched.
In the announcement today, the global biotechnology company cited collaboration...
Government should invest in Australia’s vaccine manufacturing capability – The Greens
In light of recent AstraZeneca approval for use in Australia, the political party reiterated the need to further diversify jab availability in the country.
The...
CSL makes record 45% profit leap, takes on vaccine manufacturing
As demand for vaccines ramps up, the blood products giant has taken on the enormous task of manufacturing COVID-19 jabs – and so far,...
Seqirus to build a world-leading vaccine facility in Tullamarine
Seqirus, a subsidiary of Victorian-based global biopharmaceutical leader CSL, has inked an agreement with the Federal Government to develop a new high-tech vaccine manufacturing...
CSL commences manufacture of University of Oxford /AstraZeneca vaccine candidate
CSL has announced it will commence manufacturing the University of Oxford/AstraZeneca AZD1222 COVID-19 vaccine candidate on Monday 9th November.
The global biotech company has separate...
CSL inks final agreement to manufacture UQ COVID-19 vaccine candidate
CSL‘s subsidiary, Seqirus, has signed a final agreement with the Federal Government for the supply of 51 million doses of the University of Queensland-CSL...
CSL to manufacture and supply two COVID-19 vaccine candidates for Australia
The Australian Government has signed an agreement with CSL under which the global biotech company will supply 51 million doses of the University of...
Queensland begins COVID-19 vaccine human trials
Innovation Minister Kate Jones has announced that human trials will begin today on the University of Queensland’s promising COVID-19 vaccine.
More than 4000 people have...
Featured Article
AVEVA and Schneider Electric spearhead digital transformation in mining
AVEVA, a global leader in industrial software driving digital transformation, has partnered with Schneider Electric to redefine what smart, sustainable mining looks like in the age of AI.
